Results 251 to 260 of about 206,658 (295)
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller +17 more
wiley +1 more source
Estimating Genetic Variability and Heritability of Morpho-Agronomic Traits of M5 Cowpea (<i>Vigna unguiculata</i> (L.) Walp) Mutant Lines. [PDF]
Ramolekwa K +5 more
europepmc +1 more source
Estimation of genetic parameters in hybrid and F<sub>2</sub> generations of aromatic fine rice for breeding improvement. [PDF]
Tareque AMMMU +4 more
europepmc +1 more source
The Paul Fearn Award for Excellence in Data Sharing in Cancer Control and Population Sciences. [PDF]
Daee D +7 more
europepmc +1 more source
Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association. [PDF]
Pryce A +11 more
europepmc +1 more source

